Sign in
4/A

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-032672

Chief Business Officer acquired 113,569 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hannah Brendan · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-19 Grant or award : show line 1 in the form +113,569 129,793 D
Loading xslF345X03/doc4a.xml…